Related Experiment Video
Updated: May 14, 2025

08:20
A New Toolkit for Evaluating Gene Functions using Conditional Cas9 Stabilization
Published on: September 2, 2021
4.0K
Targeted Control of Gene Expression Using CRISPR-Associated Endoribonucleases
Sagar J Parikh1, Heather M Terron1, Luke A Burgard1,2
1Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, CA 92697, USA.
Cells
|April 11, 2025
Summary
We developed DREDGE, a new gene regulation method using CRISPR-Cas12a to precisely control gene expression. This direct repeat-enabled downregulation of gene expression offers highly selective and reversible gene silencing.
Area of Science:
- Molecular Biology
- Gene Regulation
- CRISPR Technology
Background:
- CRISPR-associated endoribonucleases (Cas RNases) offer sequence-specific RNA cleavage.
- Direct repeats (DRs) are key recognition sites for Cas RNases.
Purpose of the Study:
- To investigate the use of Cas RNases for gene expression regulation.
- To develop a novel method, DREDGE, for targeted gene downregulation.
Main Methods:
- Screening of five Cas RNases, identifying dCas12a as most efficient.
- Implementing DREDGE in doxycycline-regulatable systems.
- Testing DREDGE on fluorescent proteins and an endogenous gene.
Main Results:
- DREDGE achieved up to 90% gene downregulation with rapid onset.
- The method demonstrated high selectivity and full reversibility.
- Successful endogenous gene regulation was achieved, including a one-step CRISPR-Cas integration.
Conclusions:
- DREDGE is an effective tool for targeted, selective, and reversible gene expression control.
- This technology presents advantages over existing gene regulation methods.
Related Concept Videos
CRISPR
48.6K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
48.6K
CRISPR and crRNAs
16.3K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.3K
Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
Conservative Site-specific Recombination and Phase Variation
5.9K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
5.9K

